Maternal herpesvirus infections and risk of acute lymphoblastic leukemia in the offspring

American Journal of Epidemiology

Volumn 158, Issue 3, 2003, Pages 207-213

  Lehtinen, Matti ^a   Koskela, Pentti ^a   Ögmundsdottir, Helga M ^b,c   Bloigu, Aini ^a   Dillner, Joakim ^d   Gudnadottir, Margret ^c   Hakulinen, Timo ^e   Kjartansdottir, Anne ^d   Kvarnung, Matias ^f   Pukkala, Eero ^g   Tulinius, Hrafn ^b,c   Lehtinen, Tuula ^h  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b ICELANDIC CANCER REGISTRY   (Iceland)

^c UNIVERSITY OF ICELAND   (Iceland)

^d Dept of Radiotherapy and Oncology   (Sweden)

^e UNIVERSITY OF HELSINKI   (Finland)

^f KAROLINSKA INSTITUTE   (Sweden)

^g FINNISH CANCER REGISTRY   (Finland)

^h TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

Antibodies; Child; Epstein Barr virus infections; Herpesvirus 4, human; Leukemia, lymphocytic, acute; Longitudinal studies; Prospective studies

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

CANCER; CHILD HEALTH; MATERNAL HEALTH; MEDICAL GEOGRAPHY; VIRAL DISEASE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BLOOD SAMPLING; CASE CONTROL STUDY; CHILD; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; CYTOMEGALOVIRUS; DISEASE PREDISPOSITION; EPSTEIN BARR VIRUS; FEMALE; FINLAND; HERPES SIMPLEX VIRUS; HERPES VIRUS; HUMAN; ICELAND; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MASS SCREENING; MOTHER; PROGENY; RISK FACTOR; SERODIAGNOSIS; VERTICAL TRANSMISSION; VIRUS INFECTION;

ADULT; AGE OF ONSET; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DNA, VIRAL; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; FINLAND; HERPESVIRUS 4, HUMAN; HUMANS; ICELAND; IMMUNOGLOBULIN M; INFANT; INFANT, NEWBORN; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; ODDS RATIO; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY TRIMESTER, FIRST; REGISTRIES; REGRESSION ANALYSIS; RISK FACTORS;

FINLAND; ICELAND;

EID: 0041626185     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/aje/kwg137     Document Type: Article

References (43)

1. Parkin DM, Kramarova E, Draper GJ, et al, eds. International incidence of childhood cancer. Vol 2. Lyon, France: International Agency for Research on Cancer, 1998. (IARC scientific publication no. 144).
2. Cancer incidence in Finland. Cancer statistics of the National Research and Development Centre for Welfare and Health. Helsinki, Finland: Finnish Cancer Registry, 1995. (Cancer Society of Finland publication no. 56).
3. MacMahon B. Is acute lymphoblastic leukemia in children virus-related? Am J Epidemiol 1992;136:916-24.
4. Kinlen LJ. Infection and childhood leukemia. Cancer Causes Control 1998;9:237-9.
5. Greaves MF. Childhood leukaemia. BMJ 2002;324:283-7.
6. Petridou E, Dalamaga M, Mentis A, et al. Evidence on the infectious etiology of childhood leukemia: the role of low herd immunity (Greece). Cancer Causes Control 2001;12:645-52.
7. Kinlen LJ, Balkwill A. Infective cause of childhood leukaemia and wartime population mixing in Orkney and Shetland, UK. (Letter). Lancet 2001;357:858.
8. Ambinder RF, Browning PJ, Lorenziana I, et al. Epstein-Barr virus and childhood Hodgkin's disease in Honduras and the United States. Blood 1993;81:462-7.
9. Koskela P, Anttila T, Bjorge T, et al. Chlamydia trachomatis infection as a risk factor for cervical cancer. Int J Cancer 2000; 85:35-9.
10. Tulinius H, Storm H, Pukkala E, et al. Cancer in the Nordic countries, 1981-86. A joint publication of the five Nordic cancer registries. APMIS 1992;100(suppl 31):1-124.
11. Heid CA, Stevens J, Livak KJ, et al. Real time quantitative PCR. Genome Res 1996;6:986-94.
12. Lo YM, Chan LY, Chan AT, et al. Quantitative and temporal correlation between circulating Epstein-Barr virus DNA and tumor recurrence in nasopharyngeal carcinoma. Cancer Res 1999;59:5452-5.
13. Hakama M, Luostarinen T, Hallmans G, et al. Joint effects of HPV16 with Chlamydia trachomatis and smoking on risk of cervical cancer: antagonism or misclassification. Cancer Causes Control 2000;11:783-90.
14. Linde A, Kallin B, Dillner J, et al. Evaluation of enzyme-linked immunosorbent assays with two synthetic peptides of Epstein-Barr virus for diagnosis of infectious mononucleosis. J Infect Dis 1990;161:903-9.
15. Wiedbrauk DJ, Bassin S. Evaluation of five enzyme immunoassays for detection of immunoglobulin M antibodies to Epstein-Barr virus capsid antigens. J Clin Microbiol 1993;31:1339-41.
16. Dopatka HD, Schuy W. Compact Epstein-Barr virus diagnosis based on a defined antigen mix and specific IgA. Res Virol 1996;147:53-66.
17. Jellum E, Andersen A, Lund-Larsen P, et al. Experiences of the Janus serum bank in Norway. Environ Health Perspect 1995;3: 85-8.
18. Gan YJ, Sullivan JL, Sixbey JW. Detection of cell free Epstein-Barr virus DNA in serum during acute infectious mononucleosis. J Infect Dis 1994;170:436-9.
19. Mork J, Lie AK, Glattre E, et al. A prospective study of human papillomavirus infection as a risk factor for head and neck carcinomas. N Engl J Med 2001;344:1125-31.
20. Lehtinen T, Luostarinen T, Dillner J, et al. Serum p53 accumulation and altered antibody response to Epstein-Barr virus proteins precede diagnosis of haematopoetic malignancies. Br J Haematol 1996;93:104-10.
21. Pukkala E. Use of record linkage in small area studies. In: Elliott P, Cuzick J, English D, et al, eds. Geographical and environmental epidemiology: methods for small area studies. New York, NY: Oxford University Press, 1990;125-31.
22. Teppo L, Lehtinen M, Pukkala E. Data quality and quality control of a population based cancer registry. Acta Oncol 1994;33: 365-9.
23. Alexander FE, Wray N, Boyle P, et al. Clustering of childhood leukemia. A European study in progress. J Epidemiol Biostat 1996;1:13-24.
24. Westerbeek RMC, Blair V, Eden OB, et al. Seasonal variations in the onset of childhood leukaemia and lymphoma. Br J Cancer 1996;78:119-24.
25. Randolph VL, Heath CW Jr. Influenza during pregnancy in relation to subsequent childhood leukemia and lymphoma. Am J Epidemiol 1974;100:399-409.
26. Westergaard T, Melbye M, Pedersen JB, et al. Birth order, sibship size and risk of Hodgkin's disease in children and young adults: a population based study of 31 million person-years. Int J Cancer 1997;72:977-81.
27. Naeher H, Gissmann L, Freese UK, et al. Subclinical Epstein-Barr virus infection of both the male and female genital tract - indication for sexual transmission. J Invest Dermatol 1992;98: 791-3.
28. van Baarle D, Hovenkamp E, Dulers NHTM, et al. High prevalence of Epstein-Barr virus type 2 among homosexual men is caused by sexual transmission. J Infect Dis 2000;81:2045-9.
29. Costa S, Barrasso R, Terzano P, et al. Detection of active Epstein-Barr virus infection in pregnant women. Eur J Clin Microbiol Infect Dis 1985;4:335-6.
30. Mueller N, Evans A, Harris NL, et al. Hodgkin's disease and Epstein Barr virus. N Engl J Med 1989;320:689-95.
31. Armstrong AA, Alexander FE, Paes RB, et al. Association of Epstein-Barr virus with pediatric Hodgkin's disease. Am J Pathol 1993;142:1683-8.
32. Liebowitz D. Epstein-Barr virus - an old dog with new tricks. N Engl J Med 1995;332:55-7.
33. Kelleher CA, Dreyfus DH, Jones JF, et al. EBV infection of T cells: potential role in malignant transformation. Semin Cancer Biol 1996;7:197-207.
34. MacKenzie J, Callagher A, Clayton RA, et al. Screening for herpesvirus genomes in common acute lymphoblastic leukemia. Leukemia 2001;15:415-21.
35. Razzouk BI, Srinavas S, Sample CE, et al. Epstein-Barr virus DNA recombination and loss in sporadic Burkitt's lymphoma. J Infect Dis 1996;173:529-35.
36. Aya T, Kinoshita T, Imai S, et al. Chromosome translocation and c-MYC activation by Epstein-Barr virus and Euphorbia tirucalli in B lymphocytes. Lancet 1991;337:1190.
37. Meru N, Lung A, Lisner R, et al. Expression of the recombination activating genes (RAG-1 and RAG-2) is not detectable in Epstein-Barr virus-associated human lymphomas. Int J Cancer 2001;92:75-8.
38. Srinavas SK, Sixbey JW. Epstein-Barr virus induction of recombination-activating genes RAG1 and RAG2. J Virol 1995; 69:8155-8.
39. Umiel T, Pattengale P, Weinberg K. Recombination activating gene-1 (RAG-1) expression in all differentiation stages of B-lineage precursor acute lymphoblastic leukaemia. Leukemia 1993;7:435-40.
40. Wiemels JL, Cazzaniga G, Daniotti M, et al. Prenatal origin of acute lymphoblastic leukemia in children. Lancet 1999;354: 1499-503.
41. Wiemels JL, Pagnaments A, Taylor GM, et al. A lack of a functional NAD(P)H:quinone oxidoreductase allele is selectively associated with pediatric leukemias that have MLL fusions. Cancer Res 1999;59:4095-9.
42. Kawanishi M. Topoisomerase I and II activities are required for Epstein-Barr virus replication. J Gen Virol 1993;74:2263-8.
43. Adams A. Replication of Epstein-Barr virus genomes. J Virol 1987;61:1743-6.